| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10965 | 2021 |
| Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction DH Kim, EA Rozhkova, IV Ulasov, SD Bader, T Rajh, MS Lesniak, ... Nature materials 9 (2), 165-171, 2010 | 717 | 2010 |
| Chemokines in tumor progression and metastasis PJ Sarvaiya, D Guo, I Ulasov, P Gabikian, MS Lesniak Oncotarget 4 (12), 2171, 2013 | 423 | 2013 |
| A high-performance nanobio photocatalyst for targeted brain cancer therapy EA Rozhkova, I Ulasov, B Lai, NM Dimitrijevic, MS Lesniak, T Rajh Nano letters 9 (9), 3337-3342, 2009 | 329 | 2009 |
| Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma AM Sonabend, IV Ulasov, MA Tyler, AA Rivera, JM Mathis, MS Lesniak Stem cells 26 (3), 831-841, 2008 | 298 | 2008 |
| Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy IV Ulasov, S Nandi, M Dey, AM Sonabend, MS Lesniak Molecular medicine 17, 103-112, 2011 | 246 | 2011 |
| WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer P Wend, S Runke, K Wend, B Anchondo, M Yesayan, M Jardon, N Hardie, ... EMBO molecular medicine 5 (2), 264-279, 2013 | 211 | 2013 |
| A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma AU Ahmed, MA Tyler, B Thaci, NG Alexiades, Y Han, IV Ulasov, ... Molecular pharmaceutics 8 (5), 1559-1572, 2011 | 162 | 2011 |
| Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma AU Ahmed, B Thaci, NG Alexiades, Y Han, S Qian, F Liu, IV Balyasnikova, ... Molecular Therapy 19 (9), 1714-1726, 2011 | 160 | 2011 |
| Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo MA Tyler, IV Ulasov, AM Sonabend, S Nandi, Y Han, S Marler, J Roth, ... Gene therapy 16 (2), 262-278, 2009 | 158 | 2009 |
| Cathepsin B: A sellsword of cancer progression O Mijanović, A Branković, AN Panin, S Savchuk, P Timashev, I Ulasov, ... Cancer letters 449, 207-214, 2019 | 150 | 2019 |
| Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 145 | 2021 |
| The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma WJ Van Houdt, YS Haviv, B Lu, M Wang, AA Rivera, IV Ulasov, ... Journal of neurosurgery 104 (4), 583-592, 2006 | 141 | 2006 |
| Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma IV Ulasov, ZB Zhu, MA Tyler, Y Han, AA Rivera, A Khramtsov, DT Curiel, ... Human gene therapy 18 (7), 589-602, 2007 | 140 | 2007 |
| The challenge for gene therapy: innate immune response to adenoviruses B Thaci, IV Ulasov, DA Wainwright, MS Lesniak Oncotarget 2 (3), 113, 2011 | 132 | 2011 |
| Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells S Nandi, IV Ulasov, MA Tyler, AQ Sugihara, L Molinero, Y Han, ZB Zhu, ... Cancer research 68 (14), 5778-5784, 2008 | 113 | 2008 |
| Brain co‐delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy Y Zou, Y Wang, S Xu, Y Liu, J Yin, DB Lovejoy, M Zheng, XJ Liang, ... Advanced Materials 34 (33), 2203958, 2022 | 108 | 2022 |
| Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model B Thaci, AU Ahmed, IV Ulasov, AL Tobias, Y Han, KS Aboody, ... Cancer gene therapy 19 (6), 431-442, 2012 | 97 | 2012 |
| Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model AU Ahmed, CE Rolle, MA Tyler, Y Han, S Sengupta, DA Wainwright, ... Molecular Therapy 18 (10), 1846-1856, 2010 | 93 | 2010 |
| A Novel Ex vivo Model System for Evaluation of Conditionally Replicative Adenoviruses Therapeutic Efficacy and Toxicity TO Kirby, A Rivera, D Rein, M Wang, I Ulasov, M Breidenbach, M Kataram, ... Clinical Cancer Research 10 (24), 8697-8703, 2004 | 89 | 2004 |
David T. CurielWashington University School of MedicineAdresse e-mail validée de wustl.edu
